Market Overview

Jim Cramer Advises His Viewers On Brink's, Medtronic And More

Share:
Related BCO
Earnings Scheduled For February 6, 2019
58 Biggest Movers From Yesterday
Related SGMO
The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs
72 Biggest Movers From Yesterday
Sangamo: A Competitive Intelligence Report On Empowers And Champions (Seeking Alpha)

On CNBC's "Mad Money Lightning Round", Jim Cramer said there was really no reason for a sell-off in Brink's Company (NYSE: BCO). He thinks the quarter was great and he wants to buy the stock.

Sangamo Therapeutics Inc (NASDAQ: SGMO) has disappointed before, but it's a great speculative stock, said Cramer.

Medtronic PLC (NYSE: MDT) is a total winner, believes Cramer.

Cramer would let Fiat Chrysler Automobiles NV (NYSE: FCAU) rally a bit and then he would sell the stock. He is not endorsing the company after the CEO passed away last summer.

GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) could trade higher from its current price level, thinks Cramer.

Cramer likes EPR Properties (NYSE: EPR). He thinks it's really good.

Posted-In: CNBC Jim Cramer Mad Money mad money Lightning RoundMedia

 

Related Articles (BCO + EPR)

View Comments and Join the Discussion!

The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug

Christian Fromhertz's iShares MSCI Emerging Markets Index Trade